PRICE T ROWE ASSOCIATES INC /MD/

Position in VKTX — Viking Therapeutics, Inc.

CIK 80255 BALTIMORE, MD

Position in VKTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,750,210

+$1,318,443 QoQ

Shares Held

121,797

+15.5% QoQ

Ownership

0.104%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#71

of 435 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. VKTX ranks #132 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	TWST	Twist Bioscience Corp	3,634,652	$373,932,997

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,750,210	121,797	+15.5%	Shares	Sole	2026-08-14
2026-03-31	$3,431,767	105,487	+15.6%	Shares	Sole	2026-05-15
2025-12-31	$3,208,557	91,223	+6.7%	Shares	Sole	2026-02-17
2025-09-30	$2,246,205	85,491	+9.4%	Shares	Sole	2025-11-14
2025-06-30	$2,071,241	78,179	+11.5%	Shares	Sole	2025-08-14
2025-03-31	$1,692,191	70,089	+15.4%	Shares	Sole	2025-05-14
2024-12-31	$2,443,533	60,724	-3.1%	Shares	Defined	2025-02-14
2024-09-30	$3,967,574	62,669	+5.0%	Shares	Defined	2024-11-14
2024-06-30	$3,163,106	59,670	-2.8%	Shares	Defined	2024-08-14
2024-03-31	$5,036,194	61,417	+11.2%	Shares	Defined	2024-05-15
2023-12-31	$1,027,941	55,236	+33.3%	Shares	Defined	2024-02-16
2023-09-30	$458,873	41,452	-9.0%	Shares	Defined	2023-11-14
2023-06-30	$738,592	45,564	—	Shares	Defined	2023-08-14
No filing history on record for this holder in this stock.